- Home
- TERN vs AVTR Comparison
TERN vs AVTR Comparison
Compare TERN & AVTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TERN | AVTR |
|---|---|---|
| Founded | 2017 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.2B |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TERN | AVTR |
|---|---|---|
| Price | $52.97 | $9.39 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 13 |
| Target Price | ★ $45.22 | $12.42 |
| AVG Volume (30 Days) | 6.2M | ★ 10.0M |
| Earning Date | 05-14-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.04 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $6,552,200,000.00 |
| Revenue This Year | N/A | $1.05 |
| Revenue Next Year | N/A | $1.86 |
| P/E Ratio | ★ N/A | $161.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.55 | $7.27 |
| 52 Week High | $53.19 | $15.93 |
Technical Indicators
Market Signals| Indicator | TERN | AVTR |
|---|---|---|
| Relative Strength Index (RSI) | 74.51 | 61.21 |
| Support Level | $52.42 | $8.90 |
| Resistance Level | $53.19 | $11.35 |
| Average True Range (ATR) | 0.07 | 0.45 |
| MACD | -0.31 | 0.07 |
| Stochastic Oscillator | 97.30 | 72.17 |
Price Performance
Historical ComparisonAbout TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About AVTR Avantor Inc.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.